comparemela.com

Ann Klopp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MD Anderson Research Highlights for May 8, 2024

MD Anderson Research Highlights for May 8, 2024
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.

Lactate-producing bacteria inside tumors found to promote resistance to radiation therapy

Lactate-producing bacteria inside tumors found to promote resistance to radiation therapy
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Lactate-producing bacteria inside tumors prom

<p>Researchers at <a href="https://www.mdanderson.org/">The University of Texas MD Anderson Cancer Center</a> have discovered that lactate-producing intratumoral bacteria drives resistance to <a href="https://www.mdanderson.org/treatment-options/radiation-therapy.html">radiation therapy</a>,&nbsp; suggesting that lactic acid-producing bacteria present in various cancers may serve as novel therapeutic targets. The study, published today in <a href="https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00328-8"><em>Cancer Cell</em></a>, reported that a particular bacterial species, <em>Lactobacillus iners </em><em>(L. iners)</em>, caused cancer cells to respond to radiation by rewiring metabolic signaling pathways to resist treatment. The researchers also found that <em>L. iners</em> was associated with poorer clinical outcomes in patients with <a href="ht

Lactate-producing intratumoral bacteria drive resistance to radiation therapy

Researchers at The University of Texas MD Anderson Cancer Center have discovered that lactate-producing intratumoral bacteria drives resistance to radiation therapy, suggesting that lactic acid-producing bacteria present in various cancers may serve as novel therapeutic targets.

PDS Biotech Announces Data from IMMUNOCERV Phase 2 Trial Investigating PDS0101 and Chemoradiotherapy in Cervical Cancer to be Featured in Oral Presentation at the ASTRO 2023 Annual Meeting

PDS Biotech Announces Data from IMMUNOCERV Phase 2 Trial Investigating PDS0101 and Chemoradiotherapy in Cervical Cancer to be Featured in Oral Presentation at the ASTRO 2023 Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.